Publicaciones en colaboración con investigadores/as de University of Paris-Sorbonne (1)

2021

  1. One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab

    European Journal of Haematology, Vol. 106, Núm. 3, pp. 389-397